Abstract
Multiple sclerosis (MS) is a chronic central nervous system (CNS) disease that is
It is characterized by inflammation, demyelination, glial scarring and neuroaxonal degeneration. Its etiology is not entirely known, although it is thought to be an autoimmune disease triggered by an unknown environmental factor associated with a genetic predisposition.
Keywords
Cladribine; Multiple sclerosis; Adult patients
Bibliographic citation
Cladribina per al tractament de l'esclerosi múltiple en pacients adults. Barcelona: Servei Català de la Salut; 2018.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/4027This item appears in following collections
The following license files are associated with this item: